BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance

Chiara Tarantelli; Elena Bernasconi; Eugenio Gaudio; Luciano Cascione; Valentina Restelli; Alberto Jesus Arribas; Filippo Spriano; Andrea Rinaldi; Afua Adjeiwaa Mensah; Ivo Kwee; Maurilio Ponzoni; Emanuele Zucca; Laura Carrassa; Maria E Riveiro; Keyvan Rezai; Anastasios Stathis; Esteban Cvitkovic; Francesco Bertoni

doi:10.1136/esmoopen-2018-000387

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

News from EMA
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Alerts

PDF

Original research

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password